カテゴリー： LP Information, 世界, 部品/材料

世界のレルゴリクスAPI市場予測 2023年-2029年

◆英語タイトル：Global Relugolix API Market Growth 2023-2029
	◆商品コード：LP23JU3443 ◆発行会社（リサーチ会社）：LP Information ◆発行日：2023年5月 ◆ページ数：112 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など ◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥556,320	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,490 ⇒換算￥834,480	見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）	USD7,320 ⇒換算￥1,112,640	見積依頼/購入/質問フォーム

★LP Informationに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のレルゴリクスAPI市場」は、過去の販売実績から2022年の世界のレルゴリクスAPIの総販売量を検討し、2023年から2029年の予測されるレルゴリクスAPIの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のレルゴリクスAPIの市場規模を掲載し、XXX百万米ドル規模の世界のレルゴリクスAPI市場の詳細な分析を提供します。本インサイトレポートは、世界のレルゴリクスAPI業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のレルゴリクスAPI市場における各社の独自のポジションをより深く理解するために、レルゴリクスAPI製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のレルゴリクスAPI市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。レルゴリクスAPIの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。レルゴリクスAPIの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。レルゴリクスAPIのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

レルゴリクスAPIの世界主要メーカーとしては、MedKoo Biosciences、 Toronto Research Chemicals、 AbMole BioScience、 TargetMol Chemicals、 Clearsynth、 Taiclone、 Cayman Chemical、 Teva API、 Metrochem API Private Limited、 Veranova、 Dr. Reddy's Laboratories、 Lee Pharma、 Lupin、 Moehs Iberica、 Medichem S.A、 Inno Pharmchem、 Changzhou Pharmaceutical Factoryなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のレルゴリクスAPI市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではレルゴリクスAPI市場をセグメンテーションし、種類別 (純度≧98%、純度≧99%)、用途別 (研究機関、製薬、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：純度≧98%、純度≧99%

・用途別区分：研究機関、製薬、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のレルゴリクスAPI市場の10年間の市場状況・展望は？
・世界および地域別に見たレルゴリクスAPI市場成長の要因は何か？
・レルゴリクスAPIの市場機会はエンドマーケットの規模によってどのように変化するのか？
・レルゴリクスAPIのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：レルゴリクスAPIの年間販売量2018-2029、地域別現状・将来分析
・レルゴリクスAPIの種類別セグメント：純度≧98%、純度≧99%
・レルゴリクスAPIの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・レルゴリクスAPIの用途別セグメント：研究機関、製薬、その他
・レルゴリクスAPIの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のレルゴリクスAPI市場
・企業別のグローバルレルゴリクスAPI市場データ：2018-2023年の年間販売量、市場シェア
・企業別のレルゴリクスAPIの年間売上：2018-2023年の売上、市場シェア
・企業別のレルゴリクスAPI販売価格
・主要企業のレルゴリクスAPI生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

レルゴリクスAPIの地域別レビュー
・地域別のレルゴリクスAPI市場規模2018-2023：年間販売量、売上
・主要国別のレルゴリクスAPI市場規模2018-2023：年間販売量、売上
・南北アメリカのレルゴリクスAPI販売の成長
・アジア太平洋のレルゴリクスAPI販売の成長
・ヨーロッパのレルゴリクスAPI販売の成長
・中東・アフリカのレルゴリクスAPI販売の成長

南北アメリカ市場
・南北アメリカの国別のレルゴリクスAPI販売量、売上（2018-2023）
・南北アメリカのレルゴリクスAPIの種類別販売量
・南北アメリカのレルゴリクスAPIの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のレルゴリクスAPI販売量、売上（2018-2023）
・アジア太平洋のレルゴリクスAPIの種類別販売量
・アジア太平洋のレルゴリクスAPIの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のレルゴリクスAPI販売量、売上（2018-2023）
・ヨーロッパのレルゴリクスAPIの種類別販売量
・ヨーロッパのレルゴリクスAPIの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のレルゴリクスAPI販売量、売上（2018-2023）
・中東・アフリカのレルゴリクスAPIの種類別販売量
・中東・アフリカのレルゴリクスAPIの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・レルゴリクスAPIの製造コスト構造分析
・レルゴリクスAPIの製造プロセス分析
・レルゴリクスAPIの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・レルゴリクスAPIの主要なグローバル販売業者
・レルゴリクスAPIの主要なグローバル顧客

地域別のレルゴリクスAPI市場予測レビュー
・地域別のレルゴリクスAPI市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・レルゴリクスAPIの種類別市場規模予測
・レルゴリクスAPIの用途別市場規模予測

主要企業分析
MedKoo Biosciences、 Toronto Research Chemicals、 AbMole BioScience、 TargetMol Chemicals、 Clearsynth、 Taiclone、 Cayman Chemical、 Teva API、 Metrochem API Private Limited、 Veranova、 Dr. Reddy's Laboratories、 Lee Pharma、 Lupin、 Moehs Iberica、 Medichem S.A、 Inno Pharmchem、 Changzhou Pharmaceutical Factory
・企業情報
・レルゴリクスAPI製品
・レルゴリクスAPI販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Relugolix is used to treat prostate cancer in men.
LPI (LP Information)’ newest research report, the “Relugolix API Industry Forecast” looks at past sales and reviews total world Relugolix API sales in 2022, providing a comprehensive analysis by region and market sector of projected Relugolix API sales for 2023 through 2029. With Relugolix API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Relugolix API industry.
This Insight Report provides a comprehensive analysis of the global Relugolix API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Relugolix API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Relugolix API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Relugolix API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Relugolix API.
The global Relugolix API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Relugolix API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Relugolix API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Relugolix API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Relugolix API players cover MedKoo Biosciences, Toronto Research Chemicals, AbMole BioScience, TargetMol Chemicals, Clearsynth, Taiclone, Cayman Chemical, Teva API and Metrochem API Private Limited, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Relugolix API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Purity ≥ 98 %
Purity ≥ 99 %
Segmentation by application
Research Institute
Pharmaceutical
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
MedKoo Biosciences
Toronto Research Chemicals
AbMole BioScience
TargetMol Chemicals
Clearsynth
Taiclone
Cayman Chemical
Teva API
Metrochem API Private Limited
Veranova
Dr. Reddy’s Laboratories
Lee Pharma
Lupin
Moehs Iberica
Medichem S.A
Inno Pharmchem
Changzhou Pharmaceutical Factory
Key Questions Addressed in this Report
What is the 10-year outlook for the global Relugolix API market?
What factors are driving Relugolix API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Relugolix API market opportunities vary by end market size?
How does Relugolix API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Relugolix API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Relugolix API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Relugolix API by Country/Region, 2018, 2022 & 2029
2.2 Relugolix API Segment by Type
2.2.1 Purity ≥ 98 %
2.2.2 Purity ≥ 99 %
2.3 Relugolix API Sales by Type
2.3.1 Global Relugolix API Sales Market Share by Type (2018-2023)
2.3.2 Global Relugolix API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Relugolix API Sale Price by Type (2018-2023)
2.4 Relugolix API Segment by Application
2.4.1 Research Institute
2.4.2 Pharmaceutical
2.4.3 Others
2.5 Relugolix API Sales by Application
2.5.1 Global Relugolix API Sale Market Share by Application (2018-2023)
2.5.2 Global Relugolix API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Relugolix API Sale Price by Application (2018-2023)
3 Global Relugolix API by Company
3.1 Global Relugolix API Breakdown Data by Company
3.1.1 Global Relugolix API Annual Sales by Company (2018-2023)
3.1.2 Global Relugolix API Sales Market Share by Company (2018-2023)
3.2 Global Relugolix API Annual Revenue by Company (2018-2023)
3.2.1 Global Relugolix API Revenue by Company (2018-2023)
3.2.2 Global Relugolix API Revenue Market Share by Company (2018-2023)
3.3 Global Relugolix API Sale Price by Company
3.4 Key Manufacturers Relugolix API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Relugolix API Product Location Distribution
3.4.2 Players Relugolix API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Relugolix API by Geographic Region
4.1 World Historic Relugolix API Market Size by Geographic Region (2018-2023)
4.1.1 Global Relugolix API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Relugolix API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Relugolix API Market Size by Country/Region (2018-2023)
4.2.1 Global Relugolix API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Relugolix API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Relugolix API Sales Growth
4.4 APAC Relugolix API Sales Growth
4.5 Europe Relugolix API Sales Growth
4.6 Middle East & Africa Relugolix API Sales Growth
5 Americas
5.1 Americas Relugolix API Sales by Country
5.1.1 Americas Relugolix API Sales by Country (2018-2023)
5.1.2 Americas Relugolix API Revenue by Country (2018-2023)
5.2 Americas Relugolix API Sales by Type
5.3 Americas Relugolix API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Relugolix API Sales by Region
6.1.1 APAC Relugolix API Sales by Region (2018-2023)
6.1.2 APAC Relugolix API Revenue by Region (2018-2023)
6.2 APAC Relugolix API Sales by Type
6.3 APAC Relugolix API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Relugolix API by Country
7.1.1 Europe Relugolix API Sales by Country (2018-2023)
7.1.2 Europe Relugolix API Revenue by Country (2018-2023)
7.2 Europe Relugolix API Sales by Type
7.3 Europe Relugolix API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Relugolix API by Country
8.1.1 Middle East & Africa Relugolix API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Relugolix API Revenue by Country (2018-2023)
8.2 Middle East & Africa Relugolix API Sales by Type
8.3 Middle East & Africa Relugolix API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Relugolix API
10.3 Manufacturing Process Analysis of Relugolix API
10.4 Industry Chain Structure of Relugolix API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Relugolix API Distributors
11.3 Relugolix API Customer
12 World Forecast Review for Relugolix API by Geographic Region
12.1 Global Relugolix API Market Size Forecast by Region
12.1.1 Global Relugolix API Forecast by Region (2024-2029)
12.1.2 Global Relugolix API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Relugolix API Forecast by Type
12.7 Global Relugolix API Forecast by Application
13 Key Players Analysis
13.1 MedKoo Biosciences
13.1.1 MedKoo Biosciences Company Information
13.1.2 MedKoo Biosciences Relugolix API Product Portfolios and Specifications
13.1.3 MedKoo Biosciences Relugolix API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 MedKoo Biosciences Main Business Overview
13.1.5 MedKoo Biosciences Latest Developments
13.2 Toronto Research Chemicals
13.2.1 Toronto Research Chemicals Company Information
13.2.2 Toronto Research Chemicals Relugolix API Product Portfolios and Specifications
13.2.3 Toronto Research Chemicals Relugolix API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Toronto Research Chemicals Main Business Overview
13.2.5 Toronto Research Chemicals Latest Developments
13.3 AbMole BioScience
13.3.1 AbMole BioScience Company Information
13.3.2 AbMole BioScience Relugolix API Product Portfolios and Specifications
13.3.3 AbMole BioScience Relugolix API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 AbMole BioScience Main Business Overview
13.3.5 AbMole BioScience Latest Developments
13.4 TargetMol Chemicals
13.4.1 TargetMol Chemicals Company Information
13.4.2 TargetMol Chemicals Relugolix API Product Portfolios and Specifications
13.4.3 TargetMol Chemicals Relugolix API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 TargetMol Chemicals Main Business Overview
13.4.5 TargetMol Chemicals Latest Developments
13.5 Clearsynth
13.5.1 Clearsynth Company Information
13.5.2 Clearsynth Relugolix API Product Portfolios and Specifications
13.5.3 Clearsynth Relugolix API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Clearsynth Main Business Overview
13.5.5 Clearsynth Latest Developments
13.6 Taiclone
13.6.1 Taiclone Company Information
13.6.2 Taiclone Relugolix API Product Portfolios and Specifications
13.6.3 Taiclone Relugolix API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Taiclone Main Business Overview
13.6.5 Taiclone Latest Developments
13.7 Cayman Chemical
13.7.1 Cayman Chemical Company Information
13.7.2 Cayman Chemical Relugolix API Product Portfolios and Specifications
13.7.3 Cayman Chemical Relugolix API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Cayman Chemical Main Business Overview
13.7.5 Cayman Chemical Latest Developments
13.8 Teva API
13.8.1 Teva API Company Information
13.8.2 Teva API Relugolix API Product Portfolios and Specifications
13.8.3 Teva API Relugolix API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Teva API Main Business Overview
13.8.5 Teva API Latest Developments
13.9 Metrochem API Private Limited
13.9.1 Metrochem API Private Limited Company Information
13.9.2 Metrochem API Private Limited Relugolix API Product Portfolios and Specifications
13.9.3 Metrochem API Private Limited Relugolix API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Metrochem API Private Limited Main Business Overview
13.9.5 Metrochem API Private Limited Latest Developments
13.10 Veranova
13.10.1 Veranova Company Information
13.10.2 Veranova Relugolix API Product Portfolios and Specifications
13.10.3 Veranova Relugolix API Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Veranova Main Business Overview
13.10.5 Veranova Latest Developments
13.11 Dr. Reddy’s Laboratories
13.11.1 Dr. Reddy’s Laboratories Company Information
13.11.2 Dr. Reddy’s Laboratories Relugolix API Product Portfolios and Specifications
13.11.3 Dr. Reddy’s Laboratories Relugolix API Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Dr. Reddy’s Laboratories Main Business Overview
13.11.5 Dr. Reddy’s Laboratories Latest Developments
13.12 Lee Pharma
13.12.1 Lee Pharma Company Information
13.12.2 Lee Pharma Relugolix API Product Portfolios and Specifications
13.12.3 Lee Pharma Relugolix API Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Lee Pharma Main Business Overview
13.12.5 Lee Pharma Latest Developments
13.13 Lupin
13.13.1 Lupin Company Information
13.13.2 Lupin Relugolix API Product Portfolios and Specifications
13.13.3 Lupin Relugolix API Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Lupin Main Business Overview
13.13.5 Lupin Latest Developments
13.14 Moehs Iberica
13.14.1 Moehs Iberica Company Information
13.14.2 Moehs Iberica Relugolix API Product Portfolios and Specifications
13.14.3 Moehs Iberica Relugolix API Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Moehs Iberica Main Business Overview
13.14.5 Moehs Iberica Latest Developments
13.15 Medichem S.A
13.15.1 Medichem S.A Company Information
13.15.2 Medichem S.A Relugolix API Product Portfolios and Specifications
13.15.3 Medichem S.A Relugolix API Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Medichem S.A Main Business Overview
13.15.5 Medichem S.A Latest Developments
13.16 Inno Pharmchem
13.16.1 Inno Pharmchem Company Information
13.16.2 Inno Pharmchem Relugolix API Product Portfolios and Specifications
13.16.3 Inno Pharmchem Relugolix API Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Inno Pharmchem Main Business Overview
13.16.5 Inno Pharmchem Latest Developments
13.17 Changzhou Pharmaceutical Factory
13.17.1 Changzhou Pharmaceutical Factory Company Information
13.17.2 Changzhou Pharmaceutical Factory Relugolix API Product Portfolios and Specifications
13.17.3 Changzhou Pharmaceutical Factory Relugolix API Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Changzhou Pharmaceutical Factory Main Business Overview
13.17.5 Changzhou Pharmaceutical Factory Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Relugolix API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Relugolix API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Purity ≥ 98 %
Table 4. Major Players of Purity ≥ 99 %
Table 5. Global Relugolix API Sales by Type (2018-2023) & (Tons)
Table 6. Global Relugolix API Sales Market Share by Type (2018-2023)
Table 7. Global Relugolix API Revenue by Type (2018-2023) & ($ million)
Table 8. Global Relugolix API Revenue Market Share by Type (2018-2023)
Table 9. Global Relugolix API Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Relugolix API Sales by Application (2018-2023) & (Tons)
Table 11. Global Relugolix API Sales Market Share by Application (2018-2023)
Table 12. Global Relugolix API Revenue by Application (2018-2023)
Table 13. Global Relugolix API Revenue Market Share by Application (2018-2023)
Table 14. Global Relugolix API Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Relugolix API Sales by Company (2018-2023) & (Tons)
Table 16. Global Relugolix API Sales Market Share by Company (2018-2023)
Table 17. Global Relugolix API Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Relugolix API Revenue Market Share by Company (2018-2023)
Table 19. Global Relugolix API Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Relugolix API Producing Area Distribution and Sales Area
Table 21. Players Relugolix API Products Offered
Table 22. Relugolix API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Relugolix API Sales by Geographic Region (2018-2023) & (Tons)
Table 26. Global Relugolix API Sales Market Share Geographic Region (2018-2023)
Table 27. Global Relugolix API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Relugolix API Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Relugolix API Sales by Country/Region (2018-2023) & (Tons)
Table 30. Global Relugolix API Sales Market Share by Country/Region (2018-2023)
Table 31. Global Relugolix API Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Relugolix API Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Relugolix API Sales by Country (2018-2023) & (Tons)
Table 34. Americas Relugolix API Sales Market Share by Country (2018-2023)
Table 35. Americas Relugolix API Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Relugolix API Revenue Market Share by Country (2018-2023)
Table 37. Americas Relugolix API Sales by Type (2018-2023) & (Tons)
Table 38. Americas Relugolix API Sales by Application (2018-2023) & (Tons)
Table 39. APAC Relugolix API Sales by Region (2018-2023) & (Tons)
Table 40. APAC Relugolix API Sales Market Share by Region (2018-2023)
Table 41. APAC Relugolix API Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Relugolix API Revenue Market Share by Region (2018-2023)
Table 43. APAC Relugolix API Sales by Type (2018-2023) & (Tons)
Table 44. APAC Relugolix API Sales by Application (2018-2023) & (Tons)
Table 45. Europe Relugolix API Sales by Country (2018-2023) & (Tons)
Table 46. Europe Relugolix API Sales Market Share by Country (2018-2023)
Table 47. Europe Relugolix API Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Relugolix API Revenue Market Share by Country (2018-2023)
Table 49. Europe Relugolix API Sales by Type (2018-2023) & (Tons)
Table 50. Europe Relugolix API Sales by Application (2018-2023) & (Tons)
Table 51. Middle East & Africa Relugolix API Sales by Country (2018-2023) & (Tons)
Table 52. Middle East & Africa Relugolix API Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Relugolix API Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Relugolix API Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Relugolix API Sales by Type (2018-2023) & (Tons)
Table 56. Middle East & Africa Relugolix API Sales by Application (2018-2023) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of Relugolix API
Table 58. Key Market Challenges & Risks of Relugolix API
Table 59. Key Industry Trends of Relugolix API
Table 60. Relugolix API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Relugolix API Distributors List
Table 63. Relugolix API Customer List
Table 64. Global Relugolix API Sales Forecast by Region (2024-2029) & (Tons)
Table 65. Global Relugolix API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Relugolix API Sales Forecast by Country (2024-2029) & (Tons)
Table 67. Americas Relugolix API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Relugolix API Sales Forecast by Region (2024-2029) & (Tons)
Table 69. APAC Relugolix API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Relugolix API Sales Forecast by Country (2024-2029) & (Tons)
Table 71. Europe Relugolix API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Relugolix API Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Middle East & Africa Relugolix API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Relugolix API Sales Forecast by Type (2024-2029) & (Tons)
Table 75. Global Relugolix API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Relugolix API Sales Forecast by Application (2024-2029) & (Tons)
Table 77. Global Relugolix API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. MedKoo Biosciences Basic Information, Relugolix API Manufacturing Base, Sales Area and Its Competitors
Table 79. MedKoo Biosciences Relugolix API Product Portfolios and Specifications
Table 80. MedKoo Biosciences Relugolix API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. MedKoo Biosciences Main Business
Table 82. MedKoo Biosciences Latest Developments
Table 83. Toronto Research Chemicals Basic Information, Relugolix API Manufacturing Base, Sales Area and Its Competitors
Table 84. Toronto Research Chemicals Relugolix API Product Portfolios and Specifications
Table 85. Toronto Research Chemicals Relugolix API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. Toronto Research Chemicals Main Business
Table 87. Toronto Research Chemicals Latest Developments
Table 88. AbMole BioScience Basic Information, Relugolix API Manufacturing Base, Sales Area and Its Competitors
Table 89. AbMole BioScience Relugolix API Product Portfolios and Specifications
Table 90. AbMole BioScience Relugolix API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. AbMole BioScience Main Business
Table 92. AbMole BioScience Latest Developments
Table 93. TargetMol Chemicals Basic Information, Relugolix API Manufacturing Base, Sales Area and Its Competitors
Table 94. TargetMol Chemicals Relugolix API Product Portfolios and Specifications
Table 95. TargetMol Chemicals Relugolix API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. TargetMol Chemicals Main Business
Table 97. TargetMol Chemicals Latest Developments
Table 98. Clearsynth Basic Information, Relugolix API Manufacturing Base, Sales Area and Its Competitors
Table 99. Clearsynth Relugolix API Product Portfolios and Specifications
Table 100. Clearsynth Relugolix API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Clearsynth Main Business
Table 102. Clearsynth Latest Developments
Table 103. Taiclone Basic Information, Relugolix API Manufacturing Base, Sales Area and Its Competitors
Table 104. Taiclone Relugolix API Product Portfolios and Specifications
Table 105. Taiclone Relugolix API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Taiclone Main Business
Table 107. Taiclone Latest Developments
Table 108. Cayman Chemical Basic Information, Relugolix API Manufacturing Base, Sales Area and Its Competitors
Table 109. Cayman Chemical Relugolix API Product Portfolios and Specifications
Table 110. Cayman Chemical Relugolix API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. Cayman Chemical Main Business
Table 112. Cayman Chemical Latest Developments
Table 113. Teva API Basic Information, Relugolix API Manufacturing Base, Sales Area and Its Competitors
Table 114. Teva API Relugolix API Product Portfolios and Specifications
Table 115. Teva API Relugolix API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. Teva API Main Business
Table 117. Teva API Latest Developments
Table 118. Metrochem API Private Limited Basic Information, Relugolix API Manufacturing Base, Sales Area and Its Competitors
Table 119. Metrochem API Private Limited Relugolix API Product Portfolios and Specifications
Table 120. Metrochem API Private Limited Relugolix API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Metrochem API Private Limited Main Business
Table 122. Metrochem API Private Limited Latest Developments
Table 123. Veranova Basic Information, Relugolix API Manufacturing Base, Sales Area and Its Competitors
Table 124. Veranova Relugolix API Product Portfolios and Specifications
Table 125. Veranova Relugolix API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. Veranova Main Business
Table 127. Veranova Latest Developments
Table 128. Dr. Reddy's Laboratories Basic Information, Relugolix API Manufacturing Base, Sales Area and Its Competitors
Table 129. Dr. Reddy's Laboratories Relugolix API Product Portfolios and Specifications
Table 130. Dr. Reddy's Laboratories Relugolix API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 131. Dr. Reddy's Laboratories Main Business
Table 132. Dr. Reddy's Laboratories Latest Developments
Table 133. Lee Pharma Basic Information, Relugolix API Manufacturing Base, Sales Area and Its Competitors
Table 134. Lee Pharma Relugolix API Product Portfolios and Specifications
Table 135. Lee Pharma Relugolix API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 136. Lee Pharma Main Business
Table 137. Lee Pharma Latest Developments
Table 138. Lupin Basic Information, Relugolix API Manufacturing Base, Sales Area and Its Competitors
Table 139. Lupin Relugolix API Product Portfolios and Specifications
Table 140. Lupin Relugolix API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 141. Lupin Main Business
Table 142. Lupin Latest Developments
Table 143. Moehs Iberica Basic Information, Relugolix API Manufacturing Base, Sales Area and Its Competitors
Table 144. Moehs Iberica Relugolix API Product Portfolios and Specifications
Table 145. Moehs Iberica Relugolix API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 146. Moehs Iberica Main Business
Table 147. Moehs Iberica Latest Developments
Table 148. Medichem S.A Basic Information, Relugolix API Manufacturing Base, Sales Area and Its Competitors
Table 149. Medichem S.A Relugolix API Product Portfolios and Specifications
Table 150. Medichem S.A Relugolix API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 151. Medichem S.A Main Business
Table 152. Medichem S.A Latest Developments
Table 153. Inno Pharmchem Basic Information, Relugolix API Manufacturing Base, Sales Area and Its Competitors
Table 154. Inno Pharmchem Relugolix API Product Portfolios and Specifications
Table 155. Inno Pharmchem Relugolix API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 156. Inno Pharmchem Main Business
Table 157. Inno Pharmchem Latest Developments
Table 158. Changzhou Pharmaceutical Factory Basic Information, Relugolix API Manufacturing Base, Sales Area and Its Competitors
Table 159. Changzhou Pharmaceutical Factory Relugolix API Product Portfolios and Specifications
Table 160. Changzhou Pharmaceutical Factory Relugolix API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 161. Changzhou Pharmaceutical Factory Main Business
Table 162. Changzhou Pharmaceutical Factory Latest Developments
List of Figures
Figure 1. Picture of Relugolix API
Figure 2. Relugolix API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Relugolix API Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Relugolix API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Relugolix API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Purity ≥ 98 %
Figure 10. Product Picture of Purity ≥ 99 %
Figure 11. Global Relugolix API Sales Market Share by Type in 2022
Figure 12. Global Relugolix API Revenue Market Share by Type (2018-2023)
Figure 13. Relugolix API Consumed in Research Institute
Figure 14. Global Relugolix API Market: Research Institute (2018-2023) & (Tons)
Figure 15. Relugolix API Consumed in Pharmaceutical
Figure 16. Global Relugolix API Market: Pharmaceutical (2018-2023) & (Tons)
Figure 17. Relugolix API Consumed in Others
Figure 18. Global Relugolix API Market: Others (2018-2023) & (Tons)
Figure 19. Global Relugolix API Sales Market Share by Application (2022)
Figure 20. Global Relugolix API Revenue Market Share by Application in 2022
Figure 21. Relugolix API Sales Market by Company in 2022 (Tons)
Figure 22. Global Relugolix API Sales Market Share by Company in 2022
Figure 23. Relugolix API Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Relugolix API Revenue Market Share by Company in 2022
Figure 25. Global Relugolix API Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Relugolix API Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Relugolix API Sales 2018-2023 (Tons)
Figure 28. Americas Relugolix API Revenue 2018-2023 ($ Millions)
Figure 29. APAC Relugolix API Sales 2018-2023 (Tons)
Figure 30. APAC Relugolix API Revenue 2018-2023 ($ Millions)
Figure 31. Europe Relugolix API Sales 2018-2023 (Tons)
Figure 32. Europe Relugolix API Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Relugolix API Sales 2018-2023 (Tons)
Figure 34. Middle East & Africa Relugolix API Revenue 2018-2023 ($ Millions)
Figure 35. Americas Relugolix API Sales Market Share by Country in 2022
Figure 36. Americas Relugolix API Revenue Market Share by Country in 2022
Figure 37. Americas Relugolix API Sales Market Share by Type (2018-2023)
Figure 38. Americas Relugolix API Sales Market Share by Application (2018-2023)
Figure 39. United States Relugolix API Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Relugolix API Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Relugolix API Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Relugolix API Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Relugolix API Sales Market Share by Region in 2022
Figure 44. APAC Relugolix API Revenue Market Share by Regions in 2022
Figure 45. APAC Relugolix API Sales Market Share by Type (2018-2023)
Figure 46. APAC Relugolix API Sales Market Share by Application (2018-2023)
Figure 47. China Relugolix API Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Relugolix API Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Relugolix API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Relugolix API Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Relugolix API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Relugolix API Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Relugolix API Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Relugolix API Sales Market Share by Country in 2022
Figure 55. Europe Relugolix API Revenue Market Share by Country in 2022
Figure 56. Europe Relugolix API Sales Market Share by Type (2018-2023)
Figure 57. Europe Relugolix API Sales Market Share by Application (2018-2023)
Figure 58. Germany Relugolix API Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Relugolix API Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Relugolix API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Relugolix API Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Relugolix API Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Relugolix API Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Relugolix API Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Relugolix API Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Relugolix API Sales Market Share by Application (2018-2023)
Figure 67. Egypt Relugolix API Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Relugolix API Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Relugolix API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Relugolix API Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Relugolix API Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Relugolix API in 2022
Figure 73. Manufacturing Process Analysis of Relugolix API
Figure 74. Industry Chain Structure of Relugolix API
Figure 75. Channels of Distribution
Figure 76. Global Relugolix API Sales Market Forecast by Region (2024-2029)
Figure 77. Global Relugolix API Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Relugolix API Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Relugolix API Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Relugolix API Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Relugolix API Revenue Market Share Forecast by Application (2024-2029)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のレルゴリクスAPI市場予測 2023年-2029年(Global Relugolix API Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のレルゴリクスAPI市場予測 2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp